Suppr超能文献

双峰HIV包膜DNA加蛋白质疫苗接种产生强效、保护性抗HIV免疫反应。

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.

作者信息

Letvin N L, Montefiori D C, Yasutomi Y, Perry H C, Davies M E, Lekutis C, Alroy M, Freed D C, Lord C I, Handt L K, Liu M A, Shiver J W

机构信息

Harvard Medical School, Beth Israel Hospital, Boston, MA 02215, USA.

出版信息

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9378-83. doi: 10.1073/pnas.94.17.9378.

Abstract

It is generally thought that an effective vaccine to prevent HIV-1 infection should elicit both strong neutralizing antibody and cytotoxic T lymphocyte responses. We recently demonstrated that potent, boostable, long-lived HIV-1 envelope (Env)-specific cytotoxic T lymphocyte responses can be elicited in rhesus monkeys using plasmid-encoded HIV-1 env DNA as the immunogen. In the present study, we show that the addition of HIV-1 Env protein to this regimen as a boosting immunogen generates a high titer neutralizing antibody response in this nonhuman primate species. Moreover, we demonstrate in a pilot study that immunization with HIV-1 env DNA (multiple doses) followed by a final immunization with HIV-1 env DNA plus HIV-1 Env protein (env gene from HXBc2 clone of HIV IIIB; Env protein from parental HIV IIIB) completely protects monkeys from infection after i.v. challenge with a chimeric virus expressing HIV-1 env (HXBc2) on a simian immmunodeficiency virusmac backbone (SHIV-HXBc2). The potent immunity and protection seen in these pilot experiments suggest that a DNA prime/DNA plus protein boost regimen warrants active investigation as a vaccine strategy to prevent HIV-1 infection.

摘要

一般认为,一种有效的预防HIV-1感染的疫苗应能引发强烈的中和抗体和细胞毒性T淋巴细胞反应。我们最近证明,使用质粒编码的HIV-1包膜(Env)DNA作为免疫原,可在恒河猴中引发强效、可增强、持久的HIV-1包膜特异性细胞毒性T淋巴细胞反应。在本研究中,我们表明在此方案中添加HIV-1 Env蛋白作为增强免疫原,可在这种非人灵长类动物中产生高滴度的中和抗体反应。此外,我们在一项初步研究中证明,先用HIV-1 env DNA(多剂)免疫,最后用HIV-1 env DNA加HIV-1 Env蛋白(HIV IIIB的HXBc2克隆的env基因;亲本HIV IIIB的Env蛋白)免疫,在静脉注射用猿猴免疫缺陷病毒-猴空泡病毒(SHIV-HXBc2)骨架表达HIV-1 env(HXBc2)的嵌合病毒攻击后,可完全保护猴子免受感染。这些初步实验中所见的强效免疫和保护作用表明,DNA初免/DNA加蛋白增强方案作为预防HIV-1感染的疫苗策略值得积极研究。

相似文献

引用本文的文献

2
Strategies for inducing effective neutralizing antibody responses against HIV-1.诱导针对 HIV-1 的有效中和抗体反应的策略。
Expert Rev Vaccines. 2019 Nov;18(11):1127-1143. doi: 10.1080/14760584.2019.1690458. Epub 2019 Dec 2.
4
DNA/MVA Vaccines for HIV/AIDS.用于治疗艾滋病毒/艾滋病的DNA/改良痘苗病毒疫苗
Vaccines (Basel). 2014 Feb 28;2(1):160-78. doi: 10.3390/vaccines2010160.
5
DNA Immunization for HIV Vaccine Development.用于HIV疫苗开发的DNA免疫接种
Vaccines (Basel). 2014 Feb 25;2(1):138-59. doi: 10.3390/vaccines2010138.

本文引用的文献

2
Humoral and cellular immunities elicited by HIV-1 vaccination.
J Pharm Sci. 1996 Dec;85(12):1317-24. doi: 10.1021/js9600991.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验